Alkem Laboratories Ltd. header image

Alkem Laboratories Ltd.

539523

Equity

ISIN INE540L01014 / Valor 30689895

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-07)
INR 5,180.00-0.23%

Alkem Laboratories Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alkem Laboratories Ltd. is an Indian multinational pharmaceutical company headquartered in Mumbai and listed on the Indian stock exchanges that develops, manufactures and markets a broad range of prescription and over‑the‑counter medicines and active pharmaceutical ingredients (APIs). The business combines a large domestic branded‑generics franchise with international sales of generics and specialty products in regulated markets such as the United States and Europe as well as in emerging markets; its therapeutic portfolio spans anti‑infectives, gastroenterology, pain management, vitamins and minerals, antidiabetics, and cardiovascular treatments. Alkem also invests in formulation and process R&D and files regulatory dossiers (including ANDAs) to support its exports, while deriving revenue from manufacturing, licensing and contract services in addition to product sales.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-2.93%1Y
42.5%3Y
36.7%5Y

Performance

22.6%1Y
24.7%3Y
23.4%5Y

Volatility

Market cap

6538 M

Market cap (USD)

Daily traded volume (Shares)

2,558

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.51%USD 34.93
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%CHF 1.06
MedCap AB
MedCap AB MedCap AB Valor: 34063678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.99%SEK 552.50
Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%SEK 122.00
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.44%SEK 34.10
Asker Healthcare Group AB
Asker Healthcare Group AB Asker Healthcare Group AB Valor: 143378021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%SEK 72.20
Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%USD 14.26
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.61%USD 266.11
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%USD 200.80
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 59.75